ACB
Price
$5.95
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
8 days until earnings call
TLRY
Price
$1.73
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
76 days until earnings call
Ad is loading...

ACB vs TLRY

Header iconACB vs TLRY Comparison
Open Charts ACB vs TLRYBanner chart's image
Aurora Cannabis
Price$5.95
Change-$0.00 (-0.00%)
Volume$852.74K
CapitalizationN/A
Tilray Brands
Price$1.73
Change-$0.00 (-0.00%)
Volume$26.02M
CapitalizationN/A
View a ticker or compare two or three
ACB vs TLRY Comparison Chart
Loading...
ACB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TLRY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ACB vs. TLRY commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACB is a Buy and TLRY is a StrongBuy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (ACB: $5.95 vs. TLRY: $1.73)
Brand notoriety: ACB and TLRY are both notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACB: 101% vs. TLRY: 109%
Market capitalization -- ACB: $238.86M vs. TLRY: $1.87B
ACB [@Pharmaceuticals: Other] is valued at $238.86M. TLRY’s [@Pharmaceuticals: Other] market capitalization is $1.87B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACB’s FA Score shows that 0 FA rating(s) are green whileTLRY’s FA Score has 0 green FA rating(s).

  • ACB’s FA Score: 0 green, 5 red.
  • TLRY’s FA Score: 0 green, 5 red.
According to our system of comparison, ACB is a better buy in the long-term than TLRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACB’s TA Score shows that 4 TA indicator(s) are bullish while TLRY’s TA Score has 6 bullish TA indicator(s).

  • ACB’s TA Score: 4 bullish, 4 bearish.
  • TLRY’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, TLRY is a better buy in the short-term than ACB.

Price Growth

ACB (@Pharmaceuticals: Other) experienced а +7.99% price change this week, while TLRY (@Pharmaceuticals: Other) price change was +9.49% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +8.21%. For the same industry, the average monthly price growth was +10.22%, and the average quarterly price growth was -2.43%.

Reported Earning Dates

ACB is expected to report earnings on Feb 06, 2025.

TLRY is expected to report earnings on Jan 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+8.21% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLRY($1.87B) has a higher market cap than ACB($239M). ACB YTD gains are higher at: 24.947 vs. TLRY (-24.783). TLRY has higher annual earnings (EBITDA): -1.23B vs. ACB (-1.64B). TLRY has more cash in the bank: 260M vs. ACB (149M). ACB has less debt than TLRY: ACB (103M) vs TLRY (529M). TLRY has higher revenues than ACB: TLRY (700M) vs ACB (212M).
ACBTLRYACB / TLRY
Capitalization239M1.87B13%
EBITDA-1.64B-1.23B133%
Gain YTD24.947-24.783-101%
P/E RatioN/A8.52-
Revenue212M700M30%
Total Cash149M260M57%
Total Debt103M529M19%
FUNDAMENTALS RATINGS
ACB vs TLRY: Fundamental Ratings
ACB
TLRY
OUTLOOK RATING
1..100
1369
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9393
PRICE GROWTH RATING
1..100
5060
P/E GROWTH RATING
1..100
10093
SEASONALITY SCORE
1..100
795

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TLRY's Valuation (53) in the Biotechnology industry is somewhat better than the same rating for ACB (94) in the Pharmaceuticals Other industry. This means that TLRY’s stock grew somewhat faster than ACB’s over the last 12 months.

TLRY's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ACB (100) in the Pharmaceuticals Other industry. This means that TLRY’s stock grew similarly to ACB’s over the last 12 months.

TLRY's SMR Rating (93) in the Biotechnology industry is in the same range as ACB (93) in the Pharmaceuticals Other industry. This means that TLRY’s stock grew similarly to ACB’s over the last 12 months.

ACB's Price Growth Rating (50) in the Pharmaceuticals Other industry is in the same range as TLRY (60) in the Biotechnology industry. This means that ACB’s stock grew similarly to TLRY’s over the last 12 months.

TLRY's P/E Growth Rating (93) in the Biotechnology industry is in the same range as ACB (100) in the Pharmaceuticals Other industry. This means that TLRY’s stock grew similarly to ACB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACBTLRY
RSI
ODDS (%)
N/A
Bullish Trend 20 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
ACB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TLRY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

ACB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACB has been closely correlated with CGC. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if ACB jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACB
1D Price
Change %
ACB100%
+0.34%
CGC - ACB
82%
Closely correlated
-0.74%
TLRY - ACB
76%
Closely correlated
+2.37%
CRON - ACB
68%
Closely correlated
+0.68%
SNDL - ACB
65%
Loosely correlated
+1.38%
OGI - ACB
52%
Loosely correlated
+1.62%
More

TLRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, TLRY has been closely correlated with CGC. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TLRY jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLRY
1D Price
Change %
TLRY100%
+2.37%
CGC - TLRY
78%
Closely correlated
-0.74%
SNDL - TLRY
76%
Closely correlated
+1.38%
ACB - TLRY
76%
Closely correlated
+0.34%
CRON - TLRY
72%
Closely correlated
+0.68%
OGI - TLRY
58%
Loosely correlated
+1.62%
More